Therefore, future studies with a larger subject size would be necessary to examine the potential importance of VEGFR2 and VEGF genes as novel genetic risk markers for VaD (particularly small-vessel VaD) and AD, respectively, in addition to the influence of NOS3 gene on AD progression. This evidence concerns the gene NOS3 and Alzheimer disease.